Style | Citing Format |
---|---|
MLA | Hajikarimloo B, et al.. "Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis." BMC Cancer, vol. 24, no. 1, 2024, pp. -. |
APA | Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH, Hasanzade A, Zare AH, Akhlaghpasand M, Tavanaei R, Tos SM (2024). Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis. BMC Cancer, 24(1), -. |
Chicago | Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH, Hasanzade A, Zare AH, Akhlaghpasand M, Tavanaei R, Tos SM. "Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis." BMC Cancer 24, no. 1 (2024): -. |
Harvard | Hajikarimloo B et al. (2024) 'Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis', BMC Cancer, 24(1), pp. -. |
Vancouver | Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH, Hasanzade A, et al.. Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis. BMC Cancer. 2024;24(1):-. |
BibTex | @article{ author = {Hajikarimloo B and Habibi MA and Kooshki A and Alvani MS and Zare AH and Hasanzade A and Zare AH and Akhlaghpasand M and Tavanaei R and Tos SM}, title = {Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis}, journal = {BMC Cancer}, volume = {24}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Hajikarimloo B AU - Habibi MA AU - Kooshki A AU - Alvani MS AU - Zare AH AU - Hasanzade A AU - Zare AH AU - Akhlaghpasand M AU - Tavanaei R AU - Tos SM TI - Dabrafenib Plus Trametinib in Low-Grade Versus High-Grade Gliomas: A Systematic Review and Meta-Analysis JO - BMC Cancer VL - 24 IS - 1 SP - EP - PY - 2024 ER - |